Vaccines, Blood & Biologics
Resources for You
June 18, 2008 Approval Letter - Zostavax (Frozen)
June 18, 2008
Our STN: BL 125123/298
Merck & Co., Inc.
Attention: Laurie MacDonald, M.D.
P.O. Box 1000
North Wales, PA 19454-1099
Dear Dr. MacDonald:
We have approved your request to supplement your biologics license application for Zoster Vaccine Live, to include changes to the package insert and patient product information for the frozen formulation.
Please submit all final printed labeling and implementation information on FDA Form 356h. Please provide a PDF-format electronic copy.
We will include information contained in the above-referenced supplement in your biologics license application file.
--- signature ---
Loris D. McVittie, Ph.D.
Division of Vaccines and Related Products Applications
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Attachment: Approved Final Draft Labeling